Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma

Fig. 2

Multiplex RT-qPCR immunotherapy panel markers predicts response to anti-PD-1 checkpoint blockade in melanoma. a CD274, PDCD1LG2, CD8A, and IRF1 transcript expression per RECIST category of DCR. Data are presented as mean with standard deviation (error bars). b Predictive performance of CD274, PDCD1LG2, CD8A, and IRF1 transcript expression by ROC curves in terms of DCR category

Back to article page